These studies reported that macrophages induced the inhibition of CD4+T cells and the expansion of Treg cells in the TME via the PD-L1/PD-1/CD80 signaling pathway, thus mediating the resistance of glioblastoma to the combination therapy of PD-1 and CTLA-4 blockades [108]. Here, CTLA4 is linked to glioblastoma.